在严重喘中准IL-5通路减少了巨细胞原始体
P Abigail Alvarado-Vazquez1, Erika Mendez-Enriquez1, Maya Salomonsson1
1Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
The Journal of allergy and clinical immunology
|November 9, 2024
概括
在严重的喘中准IL-5/IL-5Rα可能会减少巨细胞种群. 这种生物疗法会影响巨细胞的原始细胞,可能有助于改善喘控制和减少乙氨基和TH2细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- 细胞生物学 细胞生物学
背景情况:
- 介质素-5 (IL-5) 和它的受体 (IL-5Rα) 是当前严重的酸性喘的治疗点.
- 乳腺母细胞 (MCs) 在过敏炎症中起作用.
研究的目的:
- 调查抗IL-5和抗IL-5Rα疗法的对巨细胞及其原始细胞的影响.
- 为了确定IL-5是否会影响巨细胞前代的行为.
主要方法:
- 在人类和小鼠的巨细胞和前代细胞上评估IL-5Rα表达.
- 在实验室中培养出具有IL-5的人类巨细胞原始体.
- 在抗IL-5或抗IL-5Rα治疗之前和之后,在重症喘患者中量化循环巨细胞前体.
- 分析了治疗后的巨细胞原始体中的基因表达.
主要成果:
- IL-5Rα在人类肺部巨细胞和原始细胞上表达,过敏性喘中水平升高.
- IL-5促进了人类巨细胞前代的增殖和/或存活.
- 在重症喘患者中,抗IL-5/IL-5Rα疗法减少了血筋细胞的前体,与改善的喘控制,降低了乙酸蛋白和降低了TH2细胞相关.
- 在本拉利祖马布治疗后,剩余的巨细胞原始体显示出与生长相关的基因表达的下调.
结论:
- 在严重喘中准IL-5/IL-5Rα可能会通过减少巨细胞种群来发挥临床益处.
- 这些发现表明,抗IL-5/IL-5Rα生物药物在喘管理中具有一种新的作用机制.
更多相关视频
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
7.6K
08:25An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
2.4K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:24T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353